| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Mar 6, 2026 | Sell(S) | 160 | $434.20 | $69K | 13K |
| Mar 6, 2026 | Sell(S) | 80 | $435.32 | $35K | 13K |
| Mar 6, 2026 | Sell(S) | 80 | $436.69 | $35K | 13K |
| Mar 6, 2026 | Sell(S) | 40 | $437.65 | $18K | 12K |
| Mar 6, 2026 | Sell(S) | 120 | $430.90 | $52K | 13K |
| Mar 6, 2026 | Sell(S) | 116 | $432.56 | $50K | 13K |
| Mar 6, 2026 | Sell(S) | 646 | $431.94 | $279K | 14K |
| Mar 6, 2026 | Sell(S) | 40 | $425.08 | $17K | 14K |
| Mar 6, 2026 | Sell(S) | 420 | $426.86 | $179K | 13K |
| Mar 6, 2026 | Sell(S) | 80 | $427.85 | $34K | 13K |
| Mar 6, 2026 | Sell(S) | 160 | $429.00 | $69K | 13K |
| Mar 6, 2026 | Sell(S) | 40 | $429.58 | $17K | 13K |
| Mar 4, 2026 | Grant(A) | 5K | — | $0 | 14K |
| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Mar 4, 2026 | Grant(A) | 7K | — | $0 | 7K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-015775) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for MADRIGAL PHARMACEUTICALS, INC.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.